Secretory pathways generating immunosuppressive NKG2D ligands New targets for therapeutic intervention

被引：83

作者：

Baragano Raneros, Aroa ^{[1
]}

Suarez-Alvarez, Beatriz ^{[2
]}

Lopez-Larrea, Carlos ^{[1
,3
]}

机构：

[1] Hosp Univ Cent Asturias, Dept Immunol, Oviedo, Spain

[2] Univ Autonoma Madrid, Inst Invest Sanitaria, Cellular Biol Renal Dis Lab, Fdn Jimenez Diaz, Madrid, Spain

[3] Fdn Renal Inigo Alvarez de Toledo, Madrid, Spain

来源：

ONCOIMMUNOLOGY | 2014年 / 3卷 / 04期

关键词：

NKs; NKG2D; soluble NKG2D ligands; shedding; exosomes; I-RELATED CHAIN; NATURAL-KILLER-CELL; ACTIVATING IMMUNORECEPTOR NKG2D; SOLUBLE UL16-BINDING PROTEIN-2; HUMAN OSTEOSARCOMA CELLS; DOWN-REGULATION; CUTTING EDGE; TUMOR-CELLS; HEPATOCELLULAR-CARCINOMA; CLINICAL-SIGNIFICANCE;

D O I：

10.4161/onci.28497

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

Natural Killer Group 2 member D (NKG2D) activating receptor, present on the surface of various immune cells, plays an important role in activating the anticancer immune response by their interaction with stress-inducible NKG2D ligands (NKG2DL) on transformed cells. However, cancer cells have developed numerous mechanisms to evade the immune system via the downregulation of NKG2DL from the cell surface, including the release of NKG2DL from the cell surface in a soluble form. Here, we review the mechanisms involved in the production of soluble NKG2DL (sNKG2DL) and the potential therapeutic strategies aiming to block the release of these immunosuppressive ligands. Therapeutically enabling the NKG2D-NKG2DL interaction would promote immunorecognition of malignant cells, thus abrogating disease progression.

引用

页数：9

共 79 条

[1]

Tumor Necrosis Factor Signaling Requires iRhom2 to Promote Trafficking and Activation of TACE [J].

Adrain, Colin ;

Zettl, Markus ;

Christova, Yonka ;

Taylor, Neil ;

Freeman, Matthew .

SCIENCE, 2012, 335 (6065) :225-228

[2]

Agüera-Gonzáles S, 2011, EUR J IMMUNOL, V41, P3667, DOI [10.1002/eji.20114165, 10.1002/eji.201141645]

[3]

2-Deoxy D-Glucose Prevents Cell Surface Expression of NKG2D Ligands through Inhibition of N-Linked Glycosylation [J].

Andresen, Lars ;

Skovbakke, Sarah Line ;

Persson, Gry ;

Hagemann-Jensen, Michael ;

Hansen, Karen Aagaard ;

Jensen, Helle ;

Skov, Soren .

JOURNAL OF IMMUNOLOGY, 2012, 188 (04) :1847-1855

[4]

Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions [J].

Arreygue-Garcia, Naela A. ;

Daneri-Navarro, Adrian ;

del Toro-Arreola, Alicia ;

Cid-Arregui, Angel ;

Gonzalez-Ramella, Oscar ;

Jave-Suarez, Luis F. ;

Aguilar-Lemarroy, Adriana ;

Troyo-Sanroman, Rogelio ;

Bravo-Cuellar, Alejandro ;

Delgado-Rizo, Vidal ;

Garcia-Iglesias, Trinidad ;

Hernandez-Flores, Georgina ;

del Toro-Arreola, Susana .

BMC CANCER, 2008, 8 (1)

[5]

A GPI anchor explains the unique biological features of the common NKG2D-ligand allele MICA*008 [J].

Ashiru, Omodele ;

Lopez-Cobo, Sheila ;

Fernandez-Messina, Lola ;

Pontes-Quero, Samuel ;

Pandolfi, Rachele ;

Reyburn, Hugh T. ;

Vales-Gomez, Mar .

BIOCHEMICAL JOURNAL, 2013, 454 :295-302

[6]

Natural Killer Cell Cytotoxicity Is Suppressed by Exposure to the Human NKG2D Ligand MICA*008 That Is Shed by Tumor Cells in Exosomes [J].

Ashiru, Omodele ;

Boutet, Philippe ;

Fernandez-Messina, Lola ;

Agueera-Gonzalez, Sonia ;

Skepper, Jeremy N. ;

Vales-Gomez, Mar ;

Reyburn, Hugh T. .

CANCER RESEARCH, 2010, 70 (02) :481-489

[7]

Metalloproteinase inhibitors: biological actions and therapeutic opportunities [J].

Baker, AH ;

Edwards, DR ;

Murphy, G .

JOURNAL OF CELL SCIENCE, 2002, 115 (19) :3719-3727

[8]

Hypoxia Induces Escape from Innate Immunity in Cancer Cells via Increased Expression of ADAM10: Role of Nitric Oxide [J].

Barsoum, Ivraym B. ;

Hamilton, Thomas K. ;

Li, Xin ;

Cotechini, Tiziana ;

Miles, Ellen A. ;

Siemens, D. Robert ;

Graham, Charles H. .

CANCER RESEARCH, 2011, 71 (24) :7433-7441

[9]

Novel Role for STAT3 in Transcriptional Regulation of NK Immune Cell Targeting Receptor MICA on Cancer Cells [J].

Bedel, Romain ;

Thiery-Vuillemin, Antoine ;

Grandclement, Camille ;

Balland, Jeremy ;

Remy-Martin, Jean-Paul ;

Kantelip, Bernadette ;

Pallandre, Jean-Rene ;

Pivot, Xavier ;

Ferrand, Christophe ;

Tiberghien, Pierre ;

Borg, Christophe .

CANCER RESEARCH, 2011, 71 (05) :1615-1626

[10]

Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion [J].

Bourboulia, Dimitra ;

Stetler-Stevenson, William G. .

SEMINARS IN CANCER BIOLOGY, 2010, 20 (03) :161-168

← 1 2 3 4 5 6 7 8 →